European Commission grants orphan drug designation to sirolimus for sickle cell disease Jan. 25, 2018 No Comments
Imara initiates proof-of-concept phase II study of IMR-687 in sickle cell anemia Jan. 23, 2018 No Comments
New phase III trial explores use of BAX-111 in pediatric severe hereditary von Willebrand disease Jan. 22, 2018 No Comments
Darbepoetin alfa biosimilar JR-131 demonstrates equivalence in phase III study Jan. 18, 2018 No Comments
Endari now available in U.S. for sickle cell disease in adult and pediatric patients Jan. 18, 2018 No Comments
Bioverativ conducts phase III trials with BIVV-009 in primary cold agglutinin disease Jan. 17, 2018 No Comments
RSS